Read + Share
Amedeo Smart
Independent Medical Education
Kositz C, Vasileva H, Mohammed N, Achan J, et al. Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial. Malar J 2024;23:54.PMID: 38383367
Email
LinkedIn
Facebook
Twitter
Privacy Policy